Vascular dysfunction in chronic obstructive pulmonary disease.
暂无分享,去创建一个
W. MacNee | D. Newby | N. Mills | E. Drost | C. Ludlam | D. McAllister | J. Maclay | Finny Paterson | W. Macnee
[1] A. Valipour,et al. Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.
[2] P. Libby,et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.
[3] D. Newby,et al. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo. , 2008, Journal of the American College of Cardiology.
[4] J. Hedner,et al. Short-term hypoxia reduces arterial stiffness in healthy men , 2008, European Journal of Applied Physiology.
[5] David G. Anderson,et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.
[6] Anthony P Reeves,et al. Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) Study. , 2007, American journal of respiratory and critical care medicine.
[7] W. MacNee,et al. Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk , 2007, Thorax.
[8] M. Viitanen,et al. Impaired Endothelial Function of Forearm Resistance Arteries in CADASIL Patients , 2007, Stroke.
[9] T. Sandström,et al. Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary heart disease. , 2007, The New England journal of medicine.
[10] W. MacNee,et al. Cardiovascular risk in chronic obstructive pulmonary disease , 2007, Respirology.
[11] Susan Murray,et al. Sex differences in severe pulmonary emphysema. , 2007, American journal of respiratory and critical care medicine.
[12] Raúl San José Estépar,et al. Gender differences in the severity of CT emphysema in COPD. , 2007, Chest.
[13] D. Newby,et al. Endothelial Fibrinolytic Capacity Predicts Future Adverse Cardiovascular Events in Patients With Coronary Heart Disease , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[14] Peter H Edwards,et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.
[15] H. Coxson,et al. Antielastin autoimmunity in tobacco smoking–induced emphysema , 2007, Nature Medicine.
[16] Paula Jerrard-Dunne,et al. Impact of Smoking and Smoking Cessation on Arterial Stiffness and Aortic Wave Reflection in Hypertension , 2007, Hypertension.
[17] Bartolome Celli,et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.
[18] L. Lind. Arterial compliance influences the measurement of flow-mediated vasodilation, but not acetylcholine-mediated forearm blood flow. The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. , 2007, Atherosclerosis.
[19] H. Struijker‐Boudier,et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. , 2006, European heart journal.
[20] E. Silverman,et al. Smoking related COPD and facial wrinkling: is there a common susceptibility? , 2006, Thorax.
[21] Tine Willum Hansen,et al. Prognostic Value of Aortic Pulse Wave Velocity as Index of Arterial Stiffness in the General Population , 2006, Circulation.
[22] Judith K Jones,et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. , 2006, Annals of epidemiology.
[23] David E Newby,et al. Diesel Exhaust Inhalation Causes Vascular Dysfunction and Impaired Endogenous Fibrinolysis , 2005, Circulation.
[24] C. Vlachopoulos,et al. Clinical appraisal of arterial stiffness: the Argonauts in front of the Golden Fleece , 2005, Heart.
[25] S. Sidney,et al. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. , 2005, Chest.
[26] D. Grobbee,et al. Measurement of flow-mediated dilatation of the brachial artery is affected by local elastic vessel wall properties in high-risk patients. , 2005, Atherosclerosis.
[27] S. Suissa,et al. Cardiovascular morbidity and mortality in COPD. , 2005, Chest.
[28] S. Tanguy,et al. and trained rats : involvement of l-arginine endothelium-dependent vasorelaxation in both sedentary Chronic hypoxia exposure depresses aortic , 2004 .
[29] J. Hankinson,et al. Standardisation of spirometry , 2005, European Respiratory Journal.
[30] D. Kass,et al. Mechanisms, pathophysiology, and therapy of arterial stiffness. , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[31] S. Fichtlscherer,et al. Prognostic Value of Systemic Endothelial Dysfunction in Patients With Acute Coronary Syndromes: Further Evidence for the Existence of the “Vulnerable” Patient , 2004, Circulation.
[32] Yasmin,et al. C-Reactive Protein Is Associated With Arterial Stiffness in Apparently Healthy Individuals , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[33] H. Struijker‐Boudier,et al. Current Perspectives on Arterial Stiffness and Pulse Pressure in Hypertension and Cardiovascular Diseases , 2003, Circulation.
[34] Don D. Sin,et al. Why Are Patients With Chronic Obstructive Pulmonary Disease at Increased Risk of Cardiovascular Diseases?: The Potential Role of Systemic Inflammation in Chronic Obstructive Pulmonary Disease , 2003 .
[35] F. Coppi,et al. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. , 2002, Journal of the American College of Cardiology.
[36] A. Quyyumi,et al. Prognostic Value of Coronary Vascular Endothelial Dysfunction , 2002, Circulation.
[37] D. Vaughan,et al. Smoking Impairs Bradykinin-Stimulated t-PA Release , 2002, Hypertension.
[38] P. Vanhoutte. Ageing and endothelial dysfunction , 2002 .
[39] E. Benjamin,et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. , 2002, Journal of the American College of Cardiology.
[40] A. Smit,et al. Endothelial Dysfunction in Patients With Coronary Artery Disease: A Comparison of Three Frequently Reported Tests , 2002, Journal of Investigative Medicine.
[41] D. Webb,et al. Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications. , 2001, British journal of clinical pharmacology.
[42] C. Jones,et al. Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide. , 2001, Clinical science.
[43] J. Johansson,et al. Gender difference in age‐related changes in vascular function , 2001, Journal of internal medicine.
[44] F. Perticone,et al. Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients , 2001, Circulation.
[45] D. Webb,et al. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. , 1999, Circulation.
[46] M. Lewis,et al. Endothelial function in Marfan syndrome: selective impairment of flow-mediated vasodilation. , 1999, Circulation.
[47] C. Jern,et al. Impaired capacity for endogenous fibrinolysis in essential hypertension , 1998, The Lancet.
[48] P. Ouyang,et al. Estrogen replacement reverses endothelial dysfunction in postmenopausal women. , 1998, The American journal of medicine.
[49] D. Webb,et al. An in vivo Model for the Assessment of Acute Fibrinolytic Capacity of the Endothelium , 1997, Thrombosis and Haemostasis.
[50] V M Hawthorne,et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study , 1996, BMJ.
[51] J. Deanfield,et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. , 1996, The New England journal of medicine.
[52] A. Yeung,et al. Close relation of endothelial function in the human coronary and peripheral circulations. , 1995, Journal of the American College of Cardiology.
[53] P. Ganz,et al. Estrogen Improves Endothelium-Dependent, Flow-Mediated Vasodilation in Postmenopausal Women , 1994, Annals of Internal Medicine.
[54] P. Boutouyrie,et al. Sympathetic activation decreases medium-sized arterial compliance in humans. , 1994, The American journal of physiology.
[55] D. Spiegelhalter,et al. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. , 1994, Journal of the American College of Cardiology.
[56] J. K. Lloyd,et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis , 1992, The Lancet.
[57] M. Lebowitz,et al. Death certificate reporting of confirmed airways obstructive disease. , 1991, American journal of epidemiology.
[58] F. Feit,et al. Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction. Report from the second Mount Sinai-New York University Reperfusion Trial. , 1989, Circulation.
[59] M Gent,et al. Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarction. , 1989, Journal of the American College of Cardiology.
[60] M S Golden,et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. , 1980, The New England journal of medicine.